| CTRI Number |
CTRI/2024/02/062556 [Registered on: 12/02/2024] Trial Registered Prospectively |
| Last Modified On: |
07/02/2024 |
| Post Graduate Thesis |
No |
| Type of Trial |
Observational |
|
Type of Study
|
Cross Sectional Study |
| Study Design |
Other |
|
Public Title of Study
|
One Health approach for management of human anthrax disease |
|
Scientific Title of Study
|
“One Health†approach for elimination of human
anthrax from a tribal district of Odisha: a randomized control trial |
| Trial Acronym |
Nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Debdutta Bhattacharya |
| Designation |
Scientist-E |
| Affiliation |
ICMR Regional Medical Research Centre Bhubaneswar |
| Address |
Room No 10, OPD Building, ICMR RMRC Chandrasekharpur, Bhubaneswar Bhubaneswar Khordha ORISSA 751023 India |
| Phone |
9886126077 |
| Fax |
|
| Email |
drdebdutta.bhattacharya@yahoo.co.in |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Debdutta Bhattacharya |
| Designation |
Scientist-E |
| Affiliation |
ICMR Regional Medical Research Centre Bhubaneswar |
| Address |
Room No 10, OPD Building, ICMR RMRC Chandrasekharpur, Bhubaneswar Bhubaneswar Khordha ORISSA 751023 India |
| Phone |
9886126077 |
| Fax |
|
| Email |
drdebdutta.bhattacharya@yahoo.co.in |
|
Details of Contact Person Public Query
|
| Name |
Dr Debdutta Bhattacharya |
| Designation |
Scientist-E |
| Affiliation |
ICMR Regional Medical Research Centre Bhubaneswar |
| Address |
Room No 10, OPD Building, ICMR RMRC Chandrasekharpur, Bhubaneswar Bhubaneswar Khordha ORISSA 751023 India |
| Phone |
9886126077 |
| Fax |
|
| Email |
drdebdutta.bhattacharya@yahoo.co.in |
|
|
Source of Monetary or Material Support
|
| ECD Division, ICMR New Delhi |
|
|
Primary Sponsor
|
| Name |
Indian Council of Medical Research |
| Address |
V. Ramalingaswami Bhawan,
P.O. Box No. 4911
Ansari Nagar, New Delhi - 110029, India |
| Type of Sponsor |
Research institution |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Debdutta Bhattacharya |
ICMR RMRC Bhubaneswar |
Room No. 10, OPD Building, ICMR-RMRC, Chandrasekharpur, Bhubaneswar Khordha ORISSA |
9886126077
drdebdutta.bhattacharya@yahoo.co.in |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Human Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
Participants will be selected based on the eligibility criteria: a) Should be an
adult (age above 18 years) and a permanent resident of Koraput district, b) willing to participate in the study. |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Nil |
Nil |
| Comparator Agent |
Nil |
Nil |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
Participants will be selected based on the eligibility criteria: a) Should be an
adult (age above 18 years) and a permanent resident of Koraput district, b) willing to participate in the study. |
|
| ExclusionCriteria |
| Details |
a) Cognitive impairment, b) having onset symptoms or infected with any of the communicable disease which can be spread through nasal or mouth droplets |
|
|
Method of Generating Random Sequence
|
Stratified randomization |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Our primary outcome is to assess the KAP of the community across the two arms at the end of the study. So, the unit of study is a household. To achieve this, we shall do cluster sampling. Interventions will be planned and implemented in the intervention district whereas only baseline and end line survey will be carried in the control district. For qualitative inputs we shall be conducting the IDIs and FGDs till saturation of information achieved (Estimated 40 IDI & 8 FGD). We will be using purposive sampling for qualitative interviews. |
Baseline at the start of the study and Endline at the end. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Secondary outcome includes assessment of disease burdens, patterns, knowledge, prevalence, and practices among the identified stakeholders from the departments of health, veterinary, environment/forest, and the community; and to evaluate the effectiveness of the interventions among the study population on anthrax burden in the control and intervention district along with cost-benefit analysis of interventions. |
Baseline at the start of the study and Endline at the end. |
|
|
Target Sample Size
|
Total Sample Size="1560" Sample Size from India="1560"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
19/02/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Zoonoses are recognized as a major concern
in developing nations, in need of a resolution. It is commonly agreed that the
detection, management, and elimination of zoonotic diseases require joint
efforts from the animal and human health sectors. Joint monitoring systems such as “One
Health†strategy are the most efficient and reliable means of addressing
zoonotic diseases such as anthrax in low-income countries. The One Health approach is already found to
have significance when implemented to tackle the newly emerging diseases like
Middle East respiratory syndrome, avian flu (H5N1), swine flu (H1N1), Ebola and
Zika virus. Management and effective control of anthrax
through One Health
concept is described as a highly
demanding approach although it needs a robust implementation globally. Over
the last 15 years, 10 districts
out of 30 revenue districts in Odisha have experienced outbreaks of
human anthrax with 1208 cases and 436 deaths [IDSP,
Odisha,
2016]. Among
those affected districts, Koraput
has more than 300 human anthrax cases including 10 deaths over the past 6
years. Almost all
the cases came from a group of indigenous tribes involved in handling and
consuming animal carcasses. Therefore, this implementation research project is planned in the district of Koraput using the "One Health" approach to demonstrate the feasibility for the elimination of human anthrax cases in
three years. To compare the effectiveness of the proposed intervention we will
be taking up another endemic district Sundargarh
as control group. |